Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning â a distributed machine learning (ML) artificial intelligence (AI) approach â to help international healthcare and research institutions identify malignant brain tumours.
The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six continents, the project demonstrated the ability to improve brain tumour detection by 33%.
âFederated learning has tremendous potential across numerous domains, particularly within healthcare, as shown by our research with Penn Medicine,â says Jason Martin, principal engineer at Intel Labs. âIts ability to protect sensitive information and data opens the door for future studies and collaboration, especially in cases where datasets would otherwise be inaccessible.